Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent …

JF Dong, MC Berndt, A Schade… - Blood, The Journal …, 2001 - ashpublications.org
JF Dong, MC Berndt, A Schade, LV McIntire, RK Andrews, JA López
Blood, The Journal of the American Society of Hematology, 2001ashpublications.org
Under conditions of high shear stress, both hemostasis and thrombosis are initiated by the
interaction of the platelet membrane glycoprotein (GP) Ib-IX-V complex with its adhesive
ligand, von Willebrand factor (vWF), in the subendothelial matrix or plasma. This interaction
involves the A1 domain of vWF and the N-terminal extracellular region of GP Ibα (His-1-Glu-
282), and it can also be induced under static conditions by the modulators ristocetin and
botrocetin. In this study, a panel of anti-vWF and anti-GP Ibα antibodies—previously …
Abstract
Under conditions of high shear stress, both hemostasis and thrombosis are initiated by the interaction of the platelet membrane glycoprotein (GP) Ib-IX-V complex with its adhesive ligand, von Willebrand factor (vWF), in the subendothelial matrix or plasma. This interaction involves the A1 domain of vWF and the N-terminal extracellular region of GP Ibα (His-1-Glu-282), and it can also be induced under static conditions by the modulators ristocetin and botrocetin. In this study, a panel of anti-vWF and anti-GP Ibα antibodies—previously characterized for their effects on ristocetin- and botrocetin-dependent vWF–GP Ib-IX-V interactions—was analyzed for their capacity to inhibit either the adhesion of Chinese hamster ovary cells expressing recombinant GP Ibα to surface-associated vWF under hydrodynamic flow or shear-stress–induced platelet aggregation. The combined results suggest that the shear-dependent interactions between vWF and GP Ibα closely correlate with ristocetin- rather than botrocetin-dependent binding under static conditions and that certain anti-vWF monoclonal antibodies are able to selectively inhibit shear-dependent platelet aggregation.
ashpublications.org